Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162–84.
Hovorka J, Korttila K, Erkola O. Nitrous oxide does not increase nausea and vomiting following gynaecological laparoscopy. Can J Anaesth 1989; 36: 145–8.
White PF, Shafer A Nausea and vomiting: causes and prophylaxis. Semin Anesth 1987; 6: 300–8.
Hirsh J. Impact of postoperative nausea and vomiting in the surgical setting. Anaesthesia 1994; 49(Suppl): 30–3.
Stockall CA. Postoperative nausea and vomiting — when will it stop? (Editorial) Can J Anesth 1999; 46: 715–8.
Naylor RJ, Inall FC. The physiology and pharmacology of postoperative nausea and vomiting. Anaesthesia 1994; 49(Suppl): 2–5.
Peroutka SJ, Snyder SH. Antiemetics: neurotransmitter receptor binding predicts therapeutic action. Lancet 1982; 1: 658–9.
Riley TJ, McKenzie R, Tantisira BR, Hamilton DL. Droperidol-ondansetron combinationversus droperidol alone for postoperative control of emesis after total abdominal hysterectomy. J Clin Anesth 1998; 10: 6–12.
Simpson RB, Russell D. Anaesthesia for daycase gynaecological laparoscopy: a survey of clinical practice in the United Kingdom. Anaesthesia 1999; 54: 51–85.
Bodner M, White PF. Antiemetic efficacy of ondansetron after outpatient laparoscopy. Anesth Analg 1991; 73: 250–4.
Dupeyron JP, Conseiller C, Levarlet M, et al. The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia. Anaesthesia 1993; 48: 214–8.
Kenny GNC, Oates JDL, Leeser J, et al. Efficacy of orally administered ondansetron in the prevention of post-operative nausea and vomiting: a dose ranging study. Br J Anaesth 1992; 68: 466–70.
Russell D, Kenny GNC. 5-HT3 antagonists in postoperative nausea and vomiting. Br J Anaesth 1992; 69: 63S-8S.
Wadibia EC. Antiemetics. South Med J 1999; 92: 162–5.
McKenzie R, Uy NTL, Riley TJ, Hamilton DL. Droperidol/ondansetron combination controls nausea and vomiting after tubal banding. Anesth Analg 1996; 83: 1218–22.
Tang J, Watcha MF, White PF. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996; 83: 304–13.
Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. Anesth Analg 1998; 86: 731–8.
Beattie WS, Lindblad T, Buckley DN, Forrest JB. Menstruation increases the risk of nausea and vomiting after laparoscopy. Anesthesiology 1993; 78: 272–6.
Koivuranta M, Jokela R, Kiviluoma K, Alahuhta S. The anti-emetic efficacy of a combination of ondansetron and droperidol. Anaesthesia 1997; 52: 863–8.
Myles PS, Hendrata M, Bennett AM, Langley M, Buckland MR. Postoperative nausea and vomiting. Propofol or thiopentone: does choice of induction agent affect outcome? Anaesth Intensive Care 1996; 24: 355–9.
Pueyo, F J, Carrascosa F, Lopez L, Irbarren MJ, Garcia-Pedrajas F, Saez A. Combination of ondansetron and droperidol in the prophylaxis of postoperative nausea and vomiting. Anesth Analg 1996; 83: 117–22.
Wrench IJ, Ward JEH, Walder AD, Hobbs GJ. The prevention of postoperative nausea and vomiting using a combination of ondansetron and droperidol. Anaesthesia 1996; 51: 776–8.
Goodman NW. Trials of postoperative antiemetics need three arms (Letter). BMJ 1999; 318: 942.
Cohen SE, Woods WA, Wyner J. Antiemetic efficacy of droperidol and metoclopramide. Anesthesiology 1984; 60: 67–9.
Fischler M, Bonnet F, Trang H, et al. The pharmacokinetics of droperidol in anesthetized patients. Anesthesiology 1986; 64: 486–9.
Pritchard JF, Bryson JC, Kernodle AE, Benedetti TL, Powell JR. Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin Pharmacol Ther 1992; 51: 51–5.
Sniadach MS, Alberts MS. A comparison of the prophylactic antiemetic effect of ondansetron and droperidol on patients undergoing gynecologic laparoscopy. Anesth Analg 1997; 85: 797–800.
Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. When placebo controlled trials are essential and equivalence trials are inadequate. BMJ 1998; 317: 875–80.
Khalil SN, Kataria B, Pearson K, et al. Ondansetron prevents postoperative nausea and vomiting in women outpatients. Anesth Analg 1994; 79: 845–51.
McKenzie R, Kovac A, O’Connor T, et al. Comparison of ondansetronversus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993; 78: 21–8.
Broomhead CJ. Physiology of postoperative nausea and vomiting. Br J Hosp Med 1995; 53: 327–30.
Sebel PS, Lowdon JD. Propofol: a new intravenous anesthetic. Anesthesiology 1989; 71: 260–77.
Di Florio T, Goucke CR. The effect of midazolam on persistent postoperative nausea and vomiting. Anesth Intensive Care 1999; 27: 38–40.
Kenny GNC. Risk factors for postoperative nausea and vomiting. Anaesthesia 1994; 49(Suppl): 6–10.
Palazzo M, Evans R Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk management. Br J Anaesth 1993; 70: 135–40.
Wrench IJ, Ward JE, Walder AD, Hobbs GJ. The prevention of postoperative nausea and vomiting using a combination of ondansetron and droperidol. Anaesthesia 1996; 51: 776–8.
Warrick PD, Belo SE. Treating rebound emesis following outpatient gynecologic laparoscopy: the efficacy of a two-dose regimen of droperidol and ondansetron. J Clin Anesth 1999; 11: 119–25.